Paroxetine News
Glaxo Reaches Settlement in Paxil Case
Hoping to avoid further litigation, GlaxoSmithKline, the world’s second-biggest pharmaceutical company, agreed to a $63.8 million settlement in a class-action suit brought against it by users of Paxil and Paxil CR. In the...
SRI medication effective in treating compulsive hoarding patients
In a paper published on-line in advance of publication in the Journal of Psychiatric Research, Sanjaya Saxena, M.D., Director of the Obsessive-Compulsive Disorders (OCD) Program at the University of California, San Diego (UCSD)...
Glaxo Facing Legal Challenges Over Paxil’s Connection to Birth Defects
A new group of lawsuits is claiming that the use of Paxil during pregnancy is responsible for children being born with significant birth defects. Studies have linked the prescription antidepressant with cardiovascular defects and...
Evelyn Pringle: Paxil Five-Year Litigation History
It would be difficult to find a better career than employment as a GlaxoSmithKline attorney, especially if job security is a top priority. Not a year goes by when the company is not doling out millions of dollars to defend...
Cost-Effectiveness Analysis of Escitalopram Compared with Paroxetine in Treatment of Generalized Anxiety Disorder in the United Kingdom
BACKGROUND: Generalized anxiety disorder (GAD) is associated with substantial economic burden.